Toxicities and Adverse Drug Reactions Experienced During Anticancer Treatment: It Is Desirable to Consider the Problem Within the International System of Pharmacovigilance
- PMID: 26195718
- DOI: 10.1200/JCO.2015.61.7613
Toxicities and Adverse Drug Reactions Experienced During Anticancer Treatment: It Is Desirable to Consider the Problem Within the International System of Pharmacovigilance
Comment in
-
Reply to P. Baldo et al.J Clin Oncol. 2015 Sep 1;33(25):2826. doi: 10.1200/JCO.2015.62.5699. Epub 2015 Jul 20. J Clin Oncol. 2015. PMID: 26195706 No abstract available.
Comment on
-
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.J Clin Oncol. 2015 Mar 10;33(8):910-5. doi: 10.1200/JCO.2014.57.9334. Epub 2015 Jan 26. J Clin Oncol. 2015. PMID: 25624439 Clinical Trial.
Similar articles
-
Reply to P. Baldo et al.J Clin Oncol. 2015 Sep 1;33(25):2826. doi: 10.1200/JCO.2015.62.5699. Epub 2015 Jul 20. J Clin Oncol. 2015. PMID: 26195706 No abstract available.
-
Side-effects of cancer drugs are under-reported in trials.Lancet Oncol. 2015 Mar;16(3):e107. doi: 10.1016/S1470-2045(15)70023-9. Epub 2015 Jan 30. Lancet Oncol. 2015. PMID: 25639368 No abstract available.
-
Doctors less likely than patients to report toxicity of cancer treatments, study shows.BMJ. 2015 Jan 27;350:h485. doi: 10.1136/bmj.h485. BMJ. 2015. PMID: 25630342 No abstract available.
-
Adjuvant therapy in the elderly: making the right decision.J Clin Oncol. 2007 May 10;25(14):1870-5. doi: 10.1200/JCO.2006.10.3457. J Clin Oncol. 2007. PMID: 17488985 Review.
-
[Fundamentals and results of cytostatic chemotherapy in some of the most common solid tumors].Acta Med Austriaca. 1999;26(3):83-8. Acta Med Austriaca. 1999. PMID: 10520375 Review. German.
Cited by
-
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.Int J Clin Pharm. 2018 Aug;40(4):748-753. doi: 10.1007/s11096-018-0711-z. Epub 2018 Aug 9. Int J Clin Pharm. 2018. PMID: 30094557 Free PMC article.
-
Pharmacovigilance in oncology.Int J Clin Pharm. 2018 Aug;40(4):832-841. doi: 10.1007/s11096-018-0706-9. Epub 2018 Aug 1. Int J Clin Pharm. 2018. PMID: 30069667 Free PMC article. Review.
-
Anticancer therapy-induced adverse drug reactions in children and preventive and control measures.Front Pharmacol. 2024 Feb 15;15:1329220. doi: 10.3389/fphar.2024.1329220. eCollection 2024. Front Pharmacol. 2024. PMID: 38425652 Free PMC article. Review.
-
Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network.Aging Clin Exp Res. 2021 Jun;33(6):1683-1687. doi: 10.1007/s40520-019-01304-5. Epub 2019 Aug 19. Aging Clin Exp Res. 2021. PMID: 31429004
-
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.Int J Clin Pharm. 2018 Aug;40(4):795-802. doi: 10.1007/s11096-018-0653-5. Epub 2018 May 21. Int J Clin Pharm. 2018. PMID: 29785683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical